Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 763 Records) |
| Query Trace: Neoplasms and NRAS[original query] |
|---|
| Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data. International journal of clinical oncology 2024 9 . Tokimasa Hida, Junji Kato, Masashi Idogawa, Takashi Tokino, Hisashi Uha |
| Adding venetoclax or hypomethylating agents to induction chemotherapy as first-line treatment for adults with acute myeloid leukemia: a retrospective case-cohort study. Therapeutic advances in hematology 2024 9 15 20406207241275850. Fangfei Xu, Kuangguo Zhou, Duanhao Gong, Wei Hua |
| Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
| Associations of SEMA7A, SEMA4D, ADAMTS10, and ADAM8 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, Microsatellite Instability Status, and Cytokine Expression in Colorectal Cancer Tissue. Current issues in molecular biology 2024 9 46 (9): 10218-10248. B?a?ej Ochman, Piotr Limanówka, Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, Wiktor Wagner, Dorota Hudy, Monika Szrot, Jerzy Zbigniew Piecuch, Jerzy Piecuch, Zenon Czuba, El?bieta ?wi?tochows |
| The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations. Annals of diagnostic pathology 2024 9 73 152375. Duygu Unal Kocabey, I Ebru Cak |
| Integrated molecular profiling of RAS, BRAF mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality. Journal of gastrointestinal oncology 2024 9 15 (4): 1580-1591. Gabriela Remonatto, Emily Ferreira Salles Pilar, Fernanda de-Paris, Pedro Guilherme Schaefer, Lúcia Maria Kliema |
| PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes. Cancer genomics & proteomics 2024 8 21 (5): 533-548. Ioannis A Voutsadak |
| Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 2024 8 8 e2400031. Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Lor |
| Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients. Journal of hematology & oncology 2024 8 17 (1): 70. Adriane Halik, Marlon Tilgner, Patricia Silva, Natalia Estrada, Robert Altwasser, Ekaterina Jahn, Michael Heuser, Hsin-An Hou, Marta Pratcorona, Robert K Hills, Klaus H Metzeler, Laurene Fenwarth, Anna Dolnik, Christine Terre, Klara Kopp, Olga Blau, Martin Szyska, Friederike Christen, Jan Krönke, Loïc Vasseur, Bob Löwenberg, Jordi Esteve, Peter J M Valk, Matthieu Duchmann, Wen-Chien Chou, David C Linch, Hartmut Döhner, Rosemary E Gale, Konstanze Döhner, Lars Bullinger, Kenichi Yoshida, Frederik Da |
| Somatic mutation phasing and haplotype extension using linked-reads in multiple myeloma. bioRxiv : the preprint server for biology 2024 8 . Steven M Foltz, Yize Li, Lijun Yao, Nadezhda V Terekhanova, Amila Weerasinghe, Qingsong Gao, Guanlan Dong, Moses Schindler, Song Cao, Hua Sun, Reyka G Jayasinghe, Robert S Fulton, Catrina C Fronick, Justin King, Daniel R Kohnen, Mark A Fiala, Ken Chen, John F DiPersio, Ravi Vij, Li Di |
| Treatment of stage IV colorectal cancer: A retrospective cohort study assessing whether failure of first?line treatment indicates failure of second?line treatment. Molecular and clinical oncology 2024 12 22 (1): 10. Hanna Peyerl, Gudrun Kreye, Martin Pecherstorfer, Josef Sing |
| Exploring somatic mutations in BRAF, KRAS, and NRAS as therapeutic targets in Saudi colorectal cancer patients through massive parallel sequencing and variant classification. Frontiers in pharmacology 2024 12 15 1498295. Thamer Abdulhamid Aljuhani, Noor Ahmad Shaik, Rahaf Talal Alqawas, Rana Y Bokhary, Mahmood Al-Mutadares, Hadiah Bassam Al Mahdi, Nuha Al-Rayes, Ashraf AbdulRahman El-Harouni, Ramu Elango, Babajan Banaganapalli, Zuhier Ahmad Aw |
| Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. International journal of cancer 2024 12 . Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell, Shivani Soni, Jae Ho Lo, Lesly Torres-Gonzalez, Sandra Algaze, Priya Jayachandran, Karam Ashouri, Alexandra Wong, Wu Zhang, Jian Yu, Lin Zhang, Benjamin A Weinberg, Emil Lou, Anthony F Shields, Richard M Goldberg, John L Marshall, Sanjay Goel, Indrakant K Singh, Heinz-Josef Le |
| Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma. Molecular diagnosis & therapy 2024 12 . E Jutten, L C L T van Kempen, G F H Diercks, B L van Leeuwen, S Kruijff, K P Weve |
| Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal Cancer. Current issues in molecular biology 2024 12 46 (12): 13617-13646. B?a?ej Ochman, Anna Kot, Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, Dominika Koszewska, Dorota Hudy, Monika Szrot, Jerzy Piecuch, Dariusz Waniczek, Zenon Czuba, El?bieta ?wi?tochows |
| Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer. Translational cancer research 2024 12 13 (11): 6235-6245. Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Matthew P De |
| Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
| A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02. International journal of hematology 2024 12 . Hironori Arai, Naoko Hosono, SungGi Chi, Kentaro Fukushima, Daisuke Ikeda, Satoshi Iyama, Akihiko Gotoh, Takayuki Ikezoe, Chikashi Yoshida, Goichi Yoshimoto, Junya Kanda, Naoto Takahashi, Emiko Sakaida, Kensuke Usuki, Takahiro Yamauchi, Yosuke Mina |
| [Molecular pathology of gastrointestinal neoplasms]. Magyar onkologia 2024 12 68 (4): 325. Tamás Strausz, László Báthory-Fülöp, Eszter Papp, Erika Tó |
| Association between KRAS mutation and alcohol consumption in Brazilian patients with colorectal cancer. Scientific reports 2024 11 14 (1): 26445. Bianca Gomes-Fernandes, Luísa Martins Trindade, Marcela de Castro Bastos Rodrigues, João Pedro Duarte Cardoso, Frederico Temponi Lima, Luíza Rogerio, Simone de Vasconcelos Generoso, Juliana Garcia Carneiro, Rodrigo Gomes da Silva, Renan Pedra de Souza, Luiz De Marco, Luciana Bastos-Rodrigu |
| The value of NGS-based multi-gene testing for differentiation of benign from malignant and risk stratification of thyroid nodules. Frontiers in oncology 2024 11 14 1414492. Mingjian Fei, Dongdong Ding, Xuanyi Ouyang, Wenyan Shen, Fenglan Zhang, Bo Zhang, Lan Q |
| Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan. Cancer medicine 2024 11 13 (22): e70360. Tokimasa Hida, Masashi Idogawa, Junji Kato, Yukiko Kiniwa, Kohei Horimoto, Sayuri Sato, Masahide Sawada, Shoichiro Tange, Masae Okura, Ryuhei Okuyama, Takashi Tokino, Hisashi Uha |
| Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment. European review for medical and pharmacological sciences 2024 11 28 (21): 4515-4525. Z Teke, A Bisgin, C Oruc Rencuzogullari, K Eren Erdogan, C K Parsak, S Kalkanli T |
| Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy. Cancer medicine 2024 10 13 (19): e70168. Xiao-Gang Wu, Wei Liu, Yan-Yan Wang, Kun Wang, Bao-Cai Xi |
| BRAF and NRAS Mutations and the Association with Prognosis of Acral Lentiginous and Nodular Melanomas in Indonesia. Asian Pacific journal of cancer prevention : APJCP 2024 10 25 (10): 3525-3531. Sumadi Lukman Anwar, Paranita Ferronika, Roby Cahyono, William Sugandhi, Gizza Dandy Prada |
| Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. JAMA oncology 2024 10 . Maria E Cabanillas, Ramona Dadu, Renata Ferrarotto, Maria Gule-Monroe, Suyu Liu, Bryan Fellman, Michelle D Williams, Mark Zafereo, Jennifer R Wang, Charles Lu, Matthew Ning, Brian A McKinley, Scott E Woodman, Dzifa Duose, Gary B Gunn, Naifa L Busaidy, |
| Follicular cell-derived thyroid carcinomas harboring novel genetic BRAF mutations: real-world data obtained using a multigene panel. Archives of endocrinology and metabolism 2024 10 68 e240067. Juliana Lima von Ammon, Gabriel Jeferson Rodríguez Machado, Rafael Reis Campos da Matta, Ana Clara Telles, Fabiane Carrijo, Bruno Alexsander França Dos Santos, Juliana Cabral Duarte Brandão, Thiago Magalhães da Silva, Fabio Hecht, Gabriel Avela Colozza-Gama, Julia Helena Tezzei, Janete Maria Cerutti, Helton Estrela Ram |
| Ancestry and somatic profile predict acral melanoma origin and prognosis. medRxiv : the preprint server for health sciences 2024 10 . Patricia Basurto-Lozada, Martha Estefania Vázquez-Cruz, Christian Molina-Aguilar, Amanda Jiang, Dekker C Deacon, Dennis Cerrato-Izaguirre, Irving Simonin-Wilmer, Fernanda G Arriaga-González, Kenya L Contreras-Ramírez, Eric T Dawson, J Rene C Wong-Ramirez, Johana Itzel Ramos-Galguera, Alethia Álvarez-Cano, Dorian Y García-Ortega, Omar Isaac García-Salinas, Alfredo Hidalgo-Miranda, Mireya Cisneros-Villanueva, Héctor Martínez-Said, Mark J Arends, Ingrid Ferreira, Mark Tullett, Rebeca Olvera-León, Louise van der Weyden, Martín Del Castillo Velasco Herrera, Rodrigo Roldán-Marín, Helena Vidaurri de la Cruz, Luis Alberto Tavares-de-la-Paz, Diego Hinojosa-Ugarte, Rachel L Belote, D Timothy Bishop, Marcos Díaz-Gay, Ludmil B Alexandrov, Yesennia Sánchez-Pérez, Gino K In, Richard M White, Patrícia A Possik, Robert L Judson-Torres, David J Adams, Carla Daniela Robles-Espino |
| Evaluation of SNaPshot and Sanger sequencing for the detection of KRAS and NRAS mutations in a sample of Venezuelan patients with colorectal cancer. Ecancermedicalscience 2025 1 18 1797. Daniela Rodríguez-Carrascal, Rafael Puche, Mary Acosta, Carlos Darío Ramír |
| Differential Gene Set Enrichment of Epithelial-Mesenchymal Transition Pathway in BRAF vs. NRAS Mutated Metastatic Melanoma. Clinical and experimental dermatology 2025 1 . Victor J Raimundi-Santos, Tyrel R Port |
- Page last reviewed:Feb 1, 2024
- Content source: